(1)
Prognostic Value of Pre-Treatment Routine Hematological Parameters in Breast Carcinoma: Advantageous or Deleterious?. Biomed. Res. Ther. 2020, 7 (8), 3916-3920. https://doi.org/10.15419/bmrat.v7i8.621.